Send OBIO Your Red Tape Reduction Ideas
If your company has experience with an unnecessary, duplicative or frustrating hurdle in the course of doing business, OBIO wants to know. Please tell us what the challenges are and how they impact your company. As part of OBIO’s engagement with the provincial government, the health science industry’s recommendations on red tape or regulatory burdens that can be addressed are being sought by the Government of Ontario.
Apply for the Creative Destruction Lab 2019/2020 Program
The Creative Destruction Lab is now accepting applications from startups for its 2019/20 seed-stage program for founders pursuing commercial opportunities predicated on translational science and technology innovations that improve human health and wellness.
Apply for the CNE Emerging Entrepreneurs Competition, August 23-25
Canada’s brightest innovators will converge in the CNE Innovation Garage over the fair's middle weekend to pitch their cutting edge inventions and compete for prize money up to $25,000 and in-kind services.
Apply for the ECHO Program
The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities.
Vena Medical Announced as 2019 ONtrepreneur
Vena Medical was accepted into the Ontario Brain Institute's ONtrepreneur program, which provides an investment of $50,000 as well as 12 months of training opportunities, one-on-one mentorship and communications support.
Curiato and TGHC Officially Launch "Smart Bedsheet" Research
Braze Mobility Awarded First Place at RBC Investor Event
Hosted by RBC in partnership with the Rick Hansen Institute, eight shortlisted international and Canadian startups that develop spinal cord injury products pitched their businesses to a panel of corporate and scientific experts, with Braze Mobility winning first place.
Flosonics Medical Chosen to Participate in Medtech Innovator's Program
MedTech Innovator announced Flosonics Medical as one of 50 companies selected to participate in the organization’s flagship four-month program, which will offer access to leading manufacturers, providers, investors, and other industry stakeholders.
Waterloo Region Now Home to Canada's First Industry-Led Medical Technology Hub
The Medical Innovation Xchange is Canada's first industry-led hub dedicated to supporting southern Ontario medtech start-ups achieve global scale while keeping their headquarters in Waterloo Region, and will house anchor tenant Intellijoint Surgical who will be joined by Penta Medical, Vena Medical, and Bloom Care Solutions.
Recapping Pitches & Pitchers
On June 10th, OBIO hosted a Pitches & Pitchers event, supported by Lumira Ventures and Whitecap Venture Partners.
Spiderwort Announces $500,000 Raise
Spiderwort announced the raise of $500,000 CAD as part of its oversubscribed Friends and Family round, along with naming new advisory board members.
Join the Ontario Trade Mission to AdvaMed, September 22-25
The Export Business Services Branch (EBSB), Ontario Ministry of Economic Development, Job Creation and Trade, is organizing a Trade Mission to attend the AdvaMed MedTech Conference in order to facilitate introductions for Ontario companies to potential customers, partners and investors.
Apply to Join a Canadian Technology Accelerator
The Canadian Technology Accelerator (CTA) initiative helps Canadian companies with an existing technology, product or service explore opportunities in foreign markets. Life Science sector sessions run in Boston, San Francisco, and Singapore.
Reviewing 'Keys to Quality'
On May 30th 2019, Martin Musiol (RA/QA Manager, IPD Inc) led “The Keys to Quality: Introduction to Good Manufacturing Practices, Quality Management Systems, and Working in Regulated Environments.”
Apply to Join the Canadian Nanotechnology PDA Mission, September 23-27 in Sao Paulo, Brazil
This Partnership Development Activity mission will focus on introducing Canadian SMEs to potential Brazilian partners for industrial R&D collaboration specific to nanotechnology with applications to the biotechnology, medicine, pharmaceuticals and cosmetics sectors.
Thornhill Medical Device Contributes to New CardioImaging Study
Thornhill Medical's investigative tool RespirAct™ Gas Control System contributed to international team led by scientists from Lawson Health Research Institute and Cedars-Sinai Medical Center.
SickKids Receives $100M Donation for Hospital Rebuild
The Hospital for Sick Children announced a $100-million donation made by Mattamy Homes founder Peter Gilgan, the largest single donation in the hospital’s history.
FACIT Portfolio Announces $750M Follow-On Financing
FACIT announced a new commercialization milestone with $750M in follow-on financing and partnerships attracted by its seed investment portfolio.
Antibe Therapeutics Unveils Lead Indication for Second Pipeline Drug
Antibe Therapeutics announced the lead indication for its second pipeline drug, ATB-352, a potent and non-addictive analgesic for the treatment of severe pain.
Why Ontario needs a network of Early Adopter Health Organizations: Biotechnology Focus
In the latest issue of Biotechnology Focus, OBIO President and CEO Gail Garland contributed a special report: Why Ontario needs a network of Early Adopter Health Organizations